Christopher Johnson

Christopher Johnson is a finance professional with extensive experience in revenue forecasting and valuation services. Currently serving as Senior Manager of Revenue Forecasting at Alexion Pharmaceuticals, Inc. since October 2022, Christopher oversees financial forecasting for the organization. Previously, Christopher held the position of Senior Associate in the Economic & Valuation Services practice at KPMG from July 2019 to October 2022, where skills in economic analysis were honed. Christopher also worked as a Consultant in R&D Finance at Alexion Pharmaceuticals from December 2021 to July 2022, focusing on revenue valuation for R&D programs. Other experiences include roles at BDO, where responsibilities encompassed business valuations and audit reviews, as well as multiple internships in finance-related positions. Christopher earned a Bachelor's Degree in Finance from Bentley University and has furthered education through international and local institutions.